Legaria María C, Bianchini Hebe M, Castello Liliana, Carloni Graciela, Di Martino Ana, Fernández Canigia Liliana, Litterio Mirta, Rollet Raquel, Rossetti Adelaida, Predari Silvia C
Subcomisión de Bacterias Anaerobias, Sociedad Argentina de Bacteriología, Micología y Parasitología Clínicas (SADEBAC), Asociación Argentina de Microbiología (AAM), Ciudad Autónoma de Buenos Aires, Argentina.
Rev Argent Microbiol. 2011 Jan-Mar;43(1):51-66. doi: 10.1590/S0325-75412011000100012.
Through time, anaerobic bacteria have shown good susceptibility to clinically useful antianaerobic agents. Nevertheless, the antimicrobial resistance profile of most of the anaerobic species related to severe infections in humans has been modified in the last years and different kinds of resistance to the most active agents have emerged, making their effectiveness less predictable. With the aim of finding an answer and for the purpose of facilitating the detection of anaerobic antimicrobial resistance, the Anaerobic Subcommittee of the Asociación Argentina de Microbiología developed the First Argentine consensus guidelines for in vitro antimicrobial susceptibility testing of clinically relevant anaerobic bacteria in humans. This document resulted from the compatibilization of the Clinical and Laboratory Standards Institute recommendations, the international literature and the work and experience of the Subcommittee. The Consensus document provides a brief taxonomy review, and exposes why and when anaerobic antimicrobial susceptibility tests should be conducted, and which antimicrobial agents can be used according to the species involved. The recommendations on how to perform, read and interpret in vitro anaerobic antimicrobial susceptibility tests with each method are exposed. Finally, the antibiotic susceptibility profile, the classification of antibiotics according to their in vitro activities, the natural and acquired mechanisms of resistance, the emerging resistance and the regional antibiotic resistance profile of clinically relevant anaerobic species are shown.
随着时间的推移,厌氧细菌对临床上有用的抗厌氧药物表现出良好的敏感性。然而,在过去几年中,与人类严重感染相关的大多数厌氧菌种的抗菌耐药性情况已经发生了变化,并且出现了对最有效的药物的不同类型耐药性,使得它们的有效性变得更难预测。为了找到答案并便于检测厌氧抗菌耐药性,阿根廷微生物学协会厌氧小组委员会制定了第一份阿根廷关于人类临床相关厌氧细菌体外抗菌药敏试验的共识指南。该文件是临床和实验室标准协会的建议、国际文献以及小组委员会的工作和经验相互协调的结果。该共识文件提供了简要的分类学综述,并阐述了为何以及何时应进行厌氧抗菌药敏试验,以及根据所涉及的菌种可以使用哪些抗菌药物。文中还介绍了关于如何使用每种方法进行、读取和解释体外厌氧抗菌药敏试验的建议。最后,展示了临床相关厌氧菌种的抗生素敏感性情况、根据其体外活性对抗生素的分类、耐药性的自然和获得性机制、新出现的耐药性以及区域抗生素耐药性情况。